Annual Short Term Debt
$5.00 M
+$4.87 M+3772.97%
31 December 2023
Summary:
Evoke Pharma annual short term debt is currently $5.00 million, with the most recent change of +$4.87 million (+3772.97%) on 31 December 2023. During the last 3 years, it has risen by +$4.75 million (+1933.35%). EVOK annual short term debt is now at all-time high.EVOK Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$5.00 M
$0.000.00%
30 September 2024
Summary:
Evoke Pharma quarterly short term debt is currently $5.00 million, unchanged on 30 September 2024. Over the past year, it has increased by +$4.99 million (+37213.43%). EVOK quarterly short term debt is now at all-time high.EVOK Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVOK Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3773.0% | +10000.0% |
| 3 y3 years | +1933.3% | +10000.0% |
| 5 y5 years | +100.0% | +10000.0% |
EVOK Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | at high | |
| 5 y | 5 years | at high | at high | ||
| alltime | all time | at high | at high |
Evoke Pharma Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.00 M(0.0%) |
| June 2024 | - | $5.00 M(0.0%) |
| Mar 2024 | - | $5.00 M(0.0%) |
| Dec 2023 | $5.00 M(+3773.0%) | $5.00 M(>+9900.0%) |
| Sept 2023 | - | $13.40 K(-74.6%) |
| June 2023 | - | $52.80 K(-42.2%) |
| Mar 2023 | - | $91.40 K(-29.2%) |
| Dec 2022 | $129.10 K(+941.1%) | $129.10 K(-8.0%) |
| Sept 2022 | - | $140.30 K(>+9900.0%) |
| June 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $12.40 K(-95.0%) | $12.40 K(-74.7%) |
| Sept 2021 | - | $49.10 K(-42.2%) |
| June 2021 | - | $84.90 K(-29.2%) |
| Mar 2021 | - | $119.90 K(-51.2%) |
| Dec 2020 | $245.90 K | $245.90 K(+75.3%) |
| Sept 2020 | - | $140.30 K(-20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $175.40 K(+66.4%) |
| Mar 2020 | - | $105.40 K(-23.9%) |
| Dec 2019 | $138.50 K(>+9900.0%) | $138.50 K(+291.2%) |
| Sept 2019 | - | $35.40 K(-49.3%) |
| June 2019 | - | $69.80 K(-32.4%) |
| Mar 2019 | - | $103.30 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2016 | - | $4.40 M(+520.9%) |
| Mar 2016 | - | $708.60 K(+385.0%) |
| Dec 2015 | $146.10 K(+15.2%) | $146.10 K(-88.3%) |
| June 2015 | - | $1.25 M(+75.6%) |
| Mar 2015 | - | $712.90 K(+462.2%) |
| Dec 2014 | $126.80 K(-91.2%) | $126.80 K(-91.2%) |
| Mar 2014 | - | $1.44 M(0.0%) |
| Dec 2013 | $1.44 M | $1.44 M(+34.8%) |
| Sept 2013 | - | $1.07 M(+52.5%) |
| June 2013 | - | $701.50 K |
FAQ
- What is Evoke Pharma annual short term debt?
- What is the all time high annual short term debt for Evoke Pharma?
- What is Evoke Pharma annual short term debt year-on-year change?
- What is Evoke Pharma quarterly short term debt?
- What is the all time high quarterly short term debt for Evoke Pharma?
- What is Evoke Pharma quarterly short term debt year-on-year change?
What is Evoke Pharma annual short term debt?
The current annual short term debt of EVOK is $5.00 M
What is the all time high annual short term debt for Evoke Pharma?
Evoke Pharma all-time high annual short term debt is $5.00 M
What is Evoke Pharma annual short term debt year-on-year change?
Over the past year, EVOK annual short term debt has changed by +$4.87 M (+3772.97%)
What is Evoke Pharma quarterly short term debt?
The current quarterly short term debt of EVOK is $5.00 M
What is the all time high quarterly short term debt for Evoke Pharma?
Evoke Pharma all-time high quarterly short term debt is $5.00 M
What is Evoke Pharma quarterly short term debt year-on-year change?
Over the past year, EVOK quarterly short term debt has changed by +$4.99 M (+37213.43%)